• Directory of Taiwan

Eosinophilic Esophagitis Drug Market Size 2021 Demand Analysis, Industry Size-Share Estimation, Top Leading Companies, Future Strategies, Business Opportunities, Growth Statistics, Revenue and Forecast to 2028

Report Ocean presents a new report on eosinophilic esophagitis drug market size, share, growth, industry trends, and forecast 2028, covering various industry elements and growth trends helpful for predicting the market’s future.

The eosinophilic esophagitis drug market size is expected to reach US$ 180.5 million by 2028 according to a new study by Report Ocean. The report “Eosinophilic Esophagitis Drug Market Report, By Product (Off-Label Drugs, Budesonide Oral Suspension, Fluticasone ODT, Mepolizumab, Reslizumab, Benralizumab, Dupilunab, Omalizumab, QAX576, AKOO2, and Losartan); By Diagnosis; By Treatment; By Regions; Global opportunity analysis and industry forecast 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Request To Download Sample of This Strategic Report:-

The market for eosinophilic esophagitis drug is driven by the growing prevalence of type II inflammatory disorders including EoE, advances in the treatment procedures, and intense competition among players for the first FDA approved drug to have a first-mover advantage. Huge unmet in EoE is also favoring the growth of the eosinophilic esophagitis drug industry. Diagnosis criteria of EoE are imperfect, as it is derived by expert opinions (with consensus between gastroenterologists, allergists, and pathologists), rather than being evidence-based. Currently, histologic criteria for EoE is not clear and it requires repeated tissue assessment to confirm disease onset, as there is no coherence between disease activity with patient symptoms.

The global eosinophilic esophagitis drug industry is fragmented based on the product, diagnosis, treatment, and region. In terms of product, the market is segmented into off-label drugs, Budesonide Oral Suspension, fluticasone ODT, Mepolizumab, Reslizumab, Benralizumab, Dupilunab, Omalizumab, QAX576, AKOO2, and losartan. Based on the diagnosis, the market for eosinophilic esophagitis is further bifurcated into upper endoscopy, esophagus biopsy, blood tests, others. Based on treatment, the eosinophilic esophagitis market is further bifurcated into dietary therapy, medication, dilation, others.

COVID-19 Impact

The COVID-19 pandemic in 2019 engulfed the world. It caused a worldwide halt. The entire global economy was affected. In addition, many people have also lost their lives. Around 252,297,094 cases and 5,091,465 deaths have been reported worldwide so far for COVID-19. The pandemic spread to almost every country in the world. In most industries, the pandemic resulted in some form of loss. As a result of the pandemic, the eosinophilic esophagitis drug market also experienced a slowdown. Statista estimates that the eosinophilic esophagitis drug market total worldwide revenue stood at approximately US$ 3.94 trillion in 2019. In 2014, the eosinophilic esophagitis drug market generated revenues of US$ 5.4 trillion at a record high.

Request To Download Sample of This Strategic Report:-

The degree of competition among prominent global companies has been developed by analyzing several leading competitors operating globally. In addition, specialist analysts examine various aspects of the eosinophilic esophagitis drug market, including market competition, market share, the most recent advancements in the industry, innovative product launches, partnerships, mergers, and acquisitions by leading companies.

Key Highlights

The Dupilunab segment of the eosinophilic esophagitis drug industry accounted for the largest revenue share in 2020 as the majority of rare disease lies within neurology therapy area. Dupilunab market held over 25% of the global share in 2020.

Based on treatment, the dietary therapy segment for the eosinophilic esophagitis drug industry is projected to constitute almost half of the market in 2028. This can be attributed to current treatment based on a strict dietary regimen owing to the onset of EoE following food allergies.

North America region is dominating the global eosinophilic esophagitis market, holding almost one-third of the market share throughout forecast period. No FDA approved drugs and huge unmet medical needs are factors responsible for such growth.

The players including Bristol-Myers Squibb, Takeda (Shire), AstraZeneca, and Regeneron pharmaceuticals together hold a significant market share of the global market in 2020.

Major Players

Regeneron Pharmaceuticals

Adare Pharmaceuticals, Inc.

Bristol-Myers Squibb

Takeda (Shire)

DBV Technologies

Falk Pharma GmbH

Allakos, Inc.

Arena Pharmaceuticals

Ception Therapeutics



Eosinophilic Esophagitis Drug, Product Outlook (Revenue – USD Million, 2016 – 2028)

Off-Label Drugs

Budesonide Oral Suspension

Fluticasone ODT









Eosinophilic Esophagitis Drug, Diagnosis Outlook (Revenue – USD Million, 2016 – 2028)

Upper Endoscopy

Esophagus Biopsy

Blood Tests


Eosinophilic Esophagitis Drug, Treatment Outlook (Revenue – USD Million, 2016 – 2028)

Dietary Therapy




Get a Sample PDF copy of the report:-

Eosinophilic Esophagitis Drug, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America











Asia Pacific





South Korea


Central & South America




Middle East & Africa


Saudi Arabia


South Africa

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)